Peter Greenleaf | President and CEO |
Joe Miller | CFO |
Jamie Harrell | Head of IR |
Olivia Brayer | Cantor Fitzgerald |
Farzin Haque | Jefferies |
Stacy Ku | TD Cowen |
Justin Kim | Oppenheimer |
Ed Arce | H.C. Wainwright |
David Martin | Bloom Burton |
Will Soghikian | SVB Securities |
Sahil Dhingra | RBC Capital Markets |
Greetings, and welcome to Aurinia Pharmaceuticals Inc.
First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions].